Local Infusion, founded in 2022, is a U.S.-based startup revolutionizing the health care, health and wellness, and pharmaceutical sectors. Its mission, encapsulated by the slogan, “We are setting a new standard for infusion therapy, because patients deserve better,” centers on enhancing the infusion therapy experience through exceptional patient-focused care and cutting-edge, proprietary AI technology.
The company streamlines access, accelerates processes, and improves outcomes in the infusion therapy landscape. By reducing the paperwork burden for clinicians, Local Infusion allows more focus on patient care, thereby nurturing a sense of comfort and community. This innovative approach attracts multiple stakeholders including health plans, health systems, employers, and pharmaceutical companies.
In its latest financial development, Local Infusion secured a $10.00M Series A investment on 01 November 2023, led by investors Meridian Street Capital and Blisce, marking a significant step towards expanding its impact across the health care sector.